478 related articles for article (PubMed ID: 14568946)
21. Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication.
Buckwold VE; Xu Z; Yen TS; Ou JH
J Gen Virol; 1997 Aug; 78 ( Pt 8)():2055-65. PubMed ID: 9267007
[TBL] [Abstract][Full Text] [Related]
22. Site-specific mutation of the hepatitis B virus enhancer II B1 element: effect on virus transcription and replication.
Xie Y; Li M; Wang Y; Hofschneider PH; Weiss L
J Gen Virol; 2001 Mar; 82(Pt 3):531-535. PubMed ID: 11172094
[TBL] [Abstract][Full Text] [Related]
23. Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15.
Yao Y; Li J; Lu Z; Tong A; Wang W; Su X; Zhou Y; Mu B; Zhou S; Li X; Chen L; Gou L; Song H; Yang J; Wei Y
Electrophoresis; 2011 Aug; 32(15):2004-12. PubMed ID: 21739463
[TBL] [Abstract][Full Text] [Related]
24. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.
Günther S; Piwon N; Iwanska A; Schilling R; Meisel H; Will H
J Virol; 1996 Dec; 70(12):8318-31. PubMed ID: 8970951
[TBL] [Abstract][Full Text] [Related]
25. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
Wang SE; Wu FY; Yu Y; Hayward GS
J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
[TBL] [Abstract][Full Text] [Related]
26. A hepatocellular carcinoma cell line producing mature hepatitis B viral particles.
Fellig Y; Almogy G; Galun E; Ketzinel-Gilad M
Biochem Biophys Res Commun; 2004 Aug; 321(2):269-74. PubMed ID: 15358171
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
28. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
29. Adeno-associated virus Rep78 protein inhibits Hepatitis B virus replication through regulation of the HBV core promoter.
Liu T; Cong M; Wang P; Jia J; Liu Y; Hermonat PL; You H
Biochem Biophys Res Commun; 2009 Jul; 385(1):106-11. PubMed ID: 19410559
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells.
Chou CK; Wang LH; Lin HM; Chi CW
Hepatology; 1992 Jul; 16(1):13-8. PubMed ID: 1319949
[TBL] [Abstract][Full Text] [Related]
31. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
32. Production of hepatitis B virus by stably transfected monocytic cell line U-937: a model for extrahepatic hepatitis B virus replication.
Müller C; Bergmann KF; Gerin JL; Korba BE
J Infect Dis; 1992 May; 165(5):929-33. PubMed ID: 1569345
[TBL] [Abstract][Full Text] [Related]
33. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells.
Rang A; Günther S; Will H
J Hepatol; 1999 Nov; 31(5):791-9. PubMed ID: 10580575
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
He YW; Guo CX; Pan YF; Peng C; Weng ZH
World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
[TBL] [Abstract][Full Text] [Related]
35. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
[TBL] [Abstract][Full Text] [Related]
36. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
37. Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.
Chung YL
FASEB J; 2013 Jun; 27(6):2316-27. PubMed ID: 23444429
[TBL] [Abstract][Full Text] [Related]
38. The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity.
Li MS; Lau TC; Chan SK; Wong CH; Ng PK; Sung JJ; Chan HL; Tsui SK
PLoS One; 2011; 6(7):e21856. PubMed ID: 21814558
[TBL] [Abstract][Full Text] [Related]
39. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues.
Urashima T; Saigo K; Kobayashi S; Imaseki H; Matsubara H; Koide Y; Asano T; Kondo Y; Koike K; Isono K
J Hepatol; 1997 Apr; 26(4):771-8. PubMed ID: 9126788
[TBL] [Abstract][Full Text] [Related]
40. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
